Impact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome
Open Access
- 14 July 2023
- journal article
- research article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (7) , 203
Abstract
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD) in diabetic patients. This study investigated the relationship between coronary local inflammation, detected by pericoronary fat attenuation index (FAI), and different blood glucose control levels in low-risk acute coronary syndrome (ACS) patients with or without diabetes. Methods: A total of 309 patients with low-risk ACS were classified into three groups: non-diabetes, well-regulated diabetes, and poorly regulated diabetes. Pericoronary FAI around the proximal or left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary artery (RCA), were evaluated by coronary computed tomography angiography (CCTA), and systemic inflammatory variables and other biochemical indicators were detected by flow cytometry. Results: Pericoronary FAI values around the proximal LAD, LCX, and RCA in poorly regulated diabetes were significantly higher than those in well-regulated diabetes and non-diabetes, whereas those in well-regulated diabetes were not statistically different from those in non-diabetes. Further, plasma glycated hemoglobin (HbA1c) level was positively correlated with the pericoronary FAI values in LAD, LCX, and RCA. However, no significantly increased systemic inflammatory mediators were found in diabetic patients with poor glycemic control. Conclusions: Diabetic patients with poor glycemic control may have higher coronary local inflammation as detected by pericoronary FAI surrounding the three major coronary arteries. Clinical Trial Registration: NCT05590858.Keywords
Funding Information
- National Natural Science Foundation of China (82070477)
- Shanghai Shenkang Hospital Development Center (SHDC12019X12)
- Program of Shanghai Academic/Technology Research Leader (22XD1421800)
- Shanghai “Rising Stars of Medical Talent” Youth Development Program “Outstanding Youth Medical Talents” (SHWSRS (2021) _099)
- Shanghai Municipal Key Clinical Specialty (shslczdzk06204)
- Shanghai Jiao Tong University School of Medicine (DLY201804)
This publication has 44 references indexed in Scilit:
- 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trialThe Lancet, 2014
- HbA1c and Coronary Heart Disease Risk Among Diabetic PatientsDiabetes Care, 2014
- A Novel Paradigm for Heart Failure With Preserved Ejection FractionJACC, 2013
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal, 2013
- Insulin and atherosclerosis: How are they related?Diabetes & Metabolism, 2013
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Intensive glycemic control and cardiovascular disease: an updateNature Reviews Cardiology, 2010
- Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literatureDiabetes, Obesity and Metabolism, 2010
- Molecular Insights and Therapeutic Targets for Diabetic Endothelial DysfunctionCirculation, 2009
- Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetesCardiovascular Research, 2004